Roslin Cell Therapies Ltd (trading as RoslinCT) is a leading global CDMO focused exclusively on advanced cell therapies. Originally spun out from the Roslin Institute in Edinburgh, Scotland, the company merged with Lykan Bioscience in 2022 and received significant investment from GHO Capital. RoslinCT provides contract development and GMP manufacturing services for cell therapy products, operating facilities in Edinburgh, UK and Hopkinton, MA, USA.
advanced cell therapy manufacturing, GMP cell processing, autologous and allogeneic cell therapies, cell therapy process development, commercial cell therapy supply
1 site worldwide
No reviews available yet.
No documents available.